The Latest research study released by Absolute Markets Insights Automated And Rapid Microbiological Tests Market with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth.In terms of revenue, global automated and rapid microbiological tests market is anticipated to grow at a CAGR of 22.12% over the forecast period. Some of the Major Companies covered in this Research are: Merck KGaA, Charles River Laboratories, MicroBio Corporation, BIOMÉRIEUX SA, Hygiena, LLC, Pall Corporation, Creative Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., HiMedia Laboratories, The MERLIN society for microbiological diagnostics GmbH and Rapid Test Methods Ltd. amongst others.

Request a report sample to gain comprehensive insights @

Global Automated and Rapid Microbiological Tests Market:

By Offering


Incubating/Reading Instrument and Proprietary Vials

Support and Services

By Methods

Growth Based Technology

  • ATP-bioluminescence
  • Colorimetric growth detection
  • Autofluorescence detection

Viability-based technologies

  • Molecular biology-based microbial detection systems
  • Endotoxin testing
  • Rapid air monitoring

Membrane Filtration

Image Analysis for Enumeration of Microorganisms


By Organization Size

Large Enterprises

Small and Medium Enterprises

By Application

Pharmaceutical manufacturing facilities

Rapid detection of airborne contamination in clean areas

Pharmaceutical microbiology laboratories

Food manufacturing and microbiology sectors

Water microbiology sectors

Raw material testing

In-process testing

Bioburden assessment

Home, and beauty product manufacturing facilities


By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic Countries
      • Denmark
      • Finland
      • Iceland
      • Sweden
      • Norway
    • Benelux Union
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • New Zealand
    • Australia
    • South Korea
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Rest of Asia Pacific 
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Purchase the latest in-depth Automated And Rapid Microbiological Tests Market report:

The growing investments across pharmaceutical firms for development of novel drugs to deliver enhanced care against illnesses is driving the demand for automated and rapid microbiological test kits and services.

The routine microbiological testing carried out by the pharmaceutical manufacturing industry is higher than any other firms owing to the stringent regulatory compliance requirements. Performing microbiological tests based on traditional culture methods is a labour-intensive, time consuming method and involves a series of complex steps handled by humans which makes it prone to errors. The on-going investments in pharmaceutical firms to develop novel antibiotics and advanced therapy medicinal products (ATMPs) is creating demand for rapid microbiological testing capabilities. Rapid microbiological methods can quickly detect or identify microorganisms in a sample using biological, biochemical, molecular or chemical means. Use of automation technologies in microbiological testing can provide significant time and cost savings and release the skilled labour from repetitive manual tasks such as media preparation and specimen preparation (planting, inoculation and other activities). This reduction in human intervention reduces the potential human errors and provides more reliable and accurate results. The automated microbial testing technologies also increases the testing volume, and frees the resources of labs for other activities.

Pharmaceutical manufacturing companies developing ATMP medicines that are based on genes (Gene Therapy Medicinal Products), cells (Cell Therapy Medicinal Products) or tissues (Tissue Engineered Products). These medicines are finding applications in treatment of diseases such as cancer, neurode­generative and cardiovascular diseases. These products have a very short shelf-life and are produced in small quantities as per requirement of individual patient which creates demand for rapid microbiological sterility testing for detecting bacterial and fungal contamination before administering the ATMP medicines to patients. The Microsart ATMP Sterile Release kit of Sartorius AG, an automated and rapid microbiological test products manufacturer, provides sterility testing results of ATMP drugs within 3 hours. Similarly, the antibody and antigen tests are performed through rapid microbiological testing methods in the development of antibiotic drugs. Thus, the growing development of novel drugs is fuelling the demand across global automated and rapid microbiological tests market.

However, the high cost associated with the massive computing power required to automate the microbiological testing and complexity in selecting the optimal method is hindering the growth of global automated and rapid microbiological tests market.

The recent outbreak of COVID-19 pandemic has fuelled the activities for developing vaccines to control the spread of this infectious disease. This race amongst researchers around the globe to develop an effective vaccine has inflated the demand for automated and rapid microbiological testing to ensure that the vaccine is safe and to get accepted by regulatory authorities. The microbiological laboratories across the globe are witnessing high demand for performing rapid immunoassay tests to detect SARS-CoV-2 antigens or antibodies. Also, ever vaccine and injection in development that is administered to patients are required to go through sterility testing. The Celsis rapid sterility testing platform of Charles River Laboratories can help companies to reduce the sterility testing of vaccine from 14 days to 6 days and that of in-process testing from 4 to 7 days to 24 hours. Thus, the requirement to rapidly perform laboratory testing of different aspects for developing COVID-19 vaccine is anticipated to fuel the global automated and rapid microbiological tests market in coming years.

Automated And Rapid Microbiological Tests Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Read Detailed Index of full Research Study @

Browse more trending reports by Absolute Markets Insights:

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Contact Name: Shreyas Tanna

Company: Absolute Markets Insights

Email Id:

Phone: IN +91-7400-24-24-24, US +1-510-420-1213